Old Web
English
Sign In
Acemap
>
Paper
>
Why START? Reflections that led to the conduct of this large long-term strategic HIV trial
Why START? Reflections that led to the conduct of this large long-term strategic HIV trial
2015
Jens D. Lundgren
Abdel Babiker
Fred M. Gordin
Sean Emery
Gerd Fätkenheuer
Jean Michel Molina
Robin Wood
James D. Neaton
Brian K. Agan
Beverly Alston Smith
Alejandro Arenas-Pinto
José Ramón Arribas
Jason V. Baker
John D. Baxter
Waldo H. Belloso
Kate Brekke
Bruce J. Brew
Susan W. Brobst
William J. Burman
Cate Carey
Richard Clark
David A. Cooper
Richard T. Davey
Guy De La Rosa
Eileen Denning
Matthew J. Dolan
Gregory J. Dore
Daniel Duprez
Ezekiel J. Emanuel
Christine Grady
Birgit Grund
Bernard Hirschel
Bruno Hoen
Fleur Hudson
Margaret Johnson
Chrispin Kambili
Karin L. Klingman
Ken M. Kunisaki
Alan Landay
Bruno Ledergerber
Sandra N. Lehrman
Ana Martinez
Sue Meger
Kelly Misar
Ronald T. Mitsuyasu
Amanda Mocroft
David Munroe
Michael Norton
Robert C. Palmer
Sarah Pett
Andrew N. Phillips
Deenan Pillay
Danielle Porter
Richard W. Price
Michael A. Proschan
Claire Rappoport
Peter Reiss
Boris Renjifo
Kevin R. Robertson
Jürgen K. Rockstroh
Gabriela Rodríguez
James F. Rooney
Michael J. Ross
Mauro Schechter
Siegfried Schwarze
Daniel Seekins
Shweta Sharma
Wendy Snowden
Amalio Telenti
Jeff Tryon
Jean van Wyk
M. Vjecha
Edwina Wright
Keywords:
Virology
Anti-Retroviral Agents
Cohort study
Disease
Medicine
Diabetes mellitus
antiretroviral therapy
human immunodeficiency virus
HIV/AIDS
treatment outcome
Correction
Source
Cite
Save
Machine Reading By IdeaReader
42
References
35
Citations
NaN
KQI
[]
map